Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Parnell Pharmaceuticals Holdings Ltd
PARNFCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.parnell.com
ISIN
AU0000XINEU9
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
PINK
Capitalization
52 622 USD
Yield for 12 month
-87.50 %
1Y
3Y
5Y
10Y
15Y
PARNF
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia. Address: Century Estate, Alexandria, NSW, Australia, 2015
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.21 USDP/E ratio
–Dividend Yield
–Current Year
+22 492 770 USD
Last Year
+19 750 662 USD
Current Quarter
–
Last Quarter
+52 822 USD
Current Year
+12 682 845 USD
Last Year
+11 534 006 USD
Current Quarter
–
Last Quarter
+30 596 USD
Key Figures PARNF
1 year
3 years
5 years
10 years
EBITDA
6 002 158 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
6.47 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
12.21 USD
Revenue TTM
34 165 616 USD
Book Value
-1.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
54.4 %
Dividend Yield
–
Gross Profit TTM
19 264 735 USD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
III 2019
Quarterly Earnings Growth YOY
–
Profit Margin
-4.16 %
Dividend Analytics PARNF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PARNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PARNF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.7113
Price Sales TTM
0.0015
Enterprise Value EBITDA
2.0573
Price Book MRQ
–
Financials PARNF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PARNF
For 52 weeks
0.0001 USD
0.0008 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
42 905
200 Day MA
0.0001 USD
Short Ratio
0.29
Shares Short
27 414
Short Percent
0.42 %
BeatStart